Showing results (1961-1970 of 2,576) with videos related to
Sort By:
Pageof 258
The Annals of Pharmacotherapy|August 13, 2010
Intravenous to oral conversion of antihypertensives: a toolkit for guideline developmentJoseph F Dasta, Bradley A Boucher, Gretchen M Brophy, et al.Atherosclerosis|August 2, 2015
Utility of a genetic risk score to predict recurrent cardiovascular events 1 year after an acute coronary syndrome: A pooled analysis of the RISCA, PRAXY, and TRIUMPH cohortsChristopher Labos, Sara C Martinez, Rui Hao Leo Wang, et al.The American Journal of Sports Medicine|June 19, 2012
Magnetic resonance imaging identification of rotator cuff retears after repair: interobserver and intraobserver agreementMichael Khazzam, John E Kuhn, Ed Mulligan, et al.The Canadian Journal of Cardiology|November 9, 2024
Bayesian Analytical Methods in Cardiovascular Clinical Trials: Why, When, and HowSamuel Heuts, Michal J Kawczynski, Ahmed Sayed, et al.Early Education and Development|October 18, 2023
Stress Intensity and Exhaustion Among Infant and Toddler Teachers: Descriptive Analysis and Associations with Sources of Stress and Coping Strategy UseHolly E Brophy-Herb, Ahnalee Brincks, Jody L Cook, et al.Journal of Neuroscience Research|October 1, 1992
Developmental expression of major myelin protein genes in the CNS of X-linked hypomyelinating mutant rumpshakerL S Mitchell, S C Gillespie, F McAllister, et al.HIV Medicine|November 5, 2020
Endothelial activation is associated with intestinal epithelial injury, systemic inflammation and treatment regimen in children living with vertically acquired HIV-1 infectionB Choudhury, J Brown, D G Ransy, et al.Diabetes Care|December 18, 2007
Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adultsSinead Brophy, Knud Yderstraede, Didac Mauricio, et al.Current Biology : CB|February 13, 2002
Neurofascin is a glial receptor for the paranodin/Caspr-contactin axonal complex at the axoglial junctionPerrine Charles, Steven Tait, Catherine Faivre-Sarrailh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistanceA M Yahanda, K M Alder, G A Fisher, et al.Pageof 258